CRO Quality Benchmarking – Phase IV Service Providers (12th Edition)

Description

Looking for our most recent market research report on this topic? Click here.

When it comes to the complex world of clinical trials, it takes a village. Whether you’ve been in the industry 15 years or 5 months, we at ISR aim to take two of the most challenging and time-consuming processes out of the abstract for outsourcers: CRO selection and CRO performance evaluation. Which provider is best to conduct a given trial? Who will perform the best? Insights from 111 experienced Phase IV outsourcers and nearly 300 service provider encounters are framed in this quality benchmarking report, addressing these questions. We leave no stone unturned by giving a sense of a provider’s brand positioning, customer loyalty, and attribute-specific strengths and weaknesses. Let us take the mystery and stress out of your Phase IV service provider selection process.

Both sponsors and providers can use this research to glean what they need to make the best decisions possible for their clinical development programs and service offerings. Informed decisions are indeed the best decisions.

Sponsors:

  • Discover which service providers your company should consider for your Phase IV studies by understanding how CROs have performed relative to your peers’ expectations
  • Gain insight into CRO customer loyalty based on overall customer satisfaction, willingness to recommend and likelihood to use again
  • Learn which provider attributes drive provider selection and explore verbatim responses from recent customers on CRO performance

Service Providers:

  • Compare how your company and your competitors have performed for recent customers across 6 attributes and 14 study types
  • Learn how to improve your marketing messaging by focusing on the areas in which customers say you excel
  • Find out which factors affect sponsor outsourcing preferences and which factors are gaining in importance for future outsourcing
  • Service Provider Selection Process
  • Service Provider Perceptions and Interactions
  • Study Data
  • Service Provider Drill Downs

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

Service Provider Selection Process

Primary Section Takeaways
Preferred Provider Agreements
Selection Attributes
Use of Outside Consultants
Select Respondent Comments

Service Provider Perceptions and Interactions

Primary Section Takeaways
Phase IV Leadership, Familiarity, and Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Summary Table
Customer Loyalty
Customer Loyalty: 3-Year Rolling Average

Study Data

Phase IV Leaders, Unprompted
Other Responses
Phase IV Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants
Outside Consultant Assistance

Service Provider Drill-downs

Catalyst Clinical Research
Clinipace
Covance
CTI Clinical Trial & Consulting
DaVita Clinical Research
DCRI-Duke
Eurofins
ICON
Innovaderm
IQVIA
Medpace
Medsource
Ora
Parexel
Pharm-Olam International
PPD
PRA
PSI
QPS
Rho
RTI International
SGS Life Sciences
Syneos Health
UBC
Worldwide Clinical Trials

Demographics

Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age
About Industry Standard Research

Additional information

License

, ,